United Kingdom

Evalve v Edwards – Review of competing public interests in grant of final injunctions

Marjan Noor

The issue of whether public interest considerations can be relied upon against the grant of a final injunction, or for a carve out in the injunction, is a very live one in disputes in relation to innovative medical devices and pharmaceuticals. In this decision, Edwards argued that, although its PASCAL product used to treat mitral Read More

The UK Food Standards Agency sets deadline for the CBD industry and provides safety advice to consumers

Eveline Van Keymeulen

On 13 February 2020, the UK Food Standards Agency (FSA) issued safety advice to users and set a deadline for businesses regarding cannabidiol (CBD) products under its supervision (i.e. mainly CBD oil, drops, foods and supplements). Noting the lack of information on the safety and contents of CBD products currently marketed in the UK, FSA Read More

Cannabis – What is being patented?

Marc Döring

The past few years have seen a global trend towards the liberalisation of cannabis policies, with cannabis becoming legalised in numerous countries and US states for recreational and/or medical use. Cannabis is currently authorised for medicinal use in more than 25 countries, including Australia, Canada, Germany, the Netherlands and the UK. And while recreational use Read More

UK Supreme Court awards Professor Shanks £2m compensation for invention of ‘outstanding benefit’ after 13 year court battle

Rafi Allos

In Shanks v Unilever Plc and others, the UK Supreme Court has, for the first time, handed down a decision on employee compensation for patented inventions. The Supreme Court overturned the previous decisions in the case and decided that Professor Shanks, an employee of Unilever’s UK research subsidiary, CRL, had made a patented invention that Read More

NICE consults on draft guideline on prescribing medicinal cannabis

Matthew Townsend

On 8 August 2019, the National Institute for Health and Care Excellence (NICE) published a draft guideline on prescribing cannabis-based medicinal products (the Draft Guideline) for consultation. The Draft Guideline, which, when finalised, will replace interim clinical guidance issued by specialist medical societies, makes recommendations regarding prescribing cannabis-based medicines for people with intractable nausea and Read More